1. Home/
  2. Compounds/
  3. selumetinib:decitabine (4:1 mol/mol)

selumetinib:decitabine (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:decitabine (4:1 mol/mol)
PharmacoGx selumetinib:decitabine (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:decitabine (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA LAD1 CTRPv2 pan-cancer AAC 0.19 5e-06
mRNA RP11-307N16.6 CTRPv2 pan-cancer AAC 0.19 6e-07
mRNA CELF2 CTRPv2 pan-cancer AAC 0.19 1e-05
mRNA LRCH4 CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA SLC43A3 CTRPv2 pan-cancer AAC 0.19 3e-06
mRNA INPP5D CTRPv2 pan-cancer AAC 0.19 5e-05
mRNA RASGRP2 CTRPv2 pan-cancer AAC 0.2 2e-06
mRNA CDT1 CTRPv2 pan-cancer AAC 0.2 1e-06
mRNA GRK2 CTRPv2 pan-cancer AAC 0.2 4e-06
mRNA EPHA1 CTRPv2 pan-cancer AAC 0.2 4e-07
Download CSV